methylprednisolone has been researched along with Deafness, Transitory in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (8.33) | 18.2507 |
2000's | 4 (33.33) | 29.6817 |
2010's | 6 (50.00) | 24.3611 |
2020's | 1 (8.33) | 2.80 |
Authors | Studies |
---|---|
Dános, K; Fent, Z; Gáborján, A; Polony, G; Szalóki, T; Székely, L; Tamás, L | 1 |
Bester, CW; Campbell, LJ; Choi, J; Eastwood, H; Newbold, C; O'Leary, SJ; Payne, MR | 1 |
Bascherini, V; Cantarini, L; Caso, F; Costa, L; Franceschini, R; Latronico, E; Rigante, D; Vitale, A | 1 |
Chae, SW; Choi, J; Im, GJ; Jung, HH; Kim, SK; Song, JJ | 1 |
Agarwal, K; Arshad, Q; Bronstein, AM; Golding, JF; Harcourt, JP; Hariri, M; Patel, M; Rea, P; Seemungal, BM | 1 |
Arai, YC; Hosokawa, M; Inoue, S; Kishida, Y; McLaughlin, M; Suetomi, K; Takemasa, R; Tani, T; Taniguchi, S; Ushida, T; Yokoyama, T | 1 |
Azuma, N; Hashimoto, N; Iwasaki, T; Kanda, C; Kitano, M; Kuroiwa, T; Matsui, K; Mishiro, Y; Morimoto, M; Nishioka, A; Okabe, M; Sano, H; Sawada, H; Sekiguchi, M; Takehara, J; Tanaka, J | 1 |
Gabra, N; Saliba, I | 1 |
Lim, CC; Tan, CB; Umapathi, T; Xu, MS | 1 |
Hoppe, B; Stefanelli, M; Woolridge, D | 1 |
Cagatay, A; Calangu, S; Eraksoy, H; Karadeniz, A; Ozsut, H | 1 |
Ilveskoski, I; Lanning, M; Mäkipernaa, A; Perkkiö, M; Pihko, H; Saarinen, UM; Salmi, TT; Wiklund, T | 1 |
3 trial(s) available for methylprednisolone and Deafness, Transitory
Article | Year |
---|---|
Electrode Impedance Fluctuations as a Biomarker for Inner Ear Pathology After Cochlear Implantation.
Topics: Adult; Aged; Cochlear Implantation; Cochlear Implants; Double-Blind Method; Electric Impedance; Female; Hearing; Hearing Loss; Humans; Male; Methylprednisolone; Middle Aged; Neuroprotective Agents; Postoperative Complications | 2017 |
Intratympanic methylprednisolone versus gentamicin in patients with unilateral Ménière's disease: a randomised, double-blind, comparative effectiveness trial.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Double-Blind Method; Female; Gentamicins; Hearing Loss; Humans; Male; Meniere Disease; Methylprednisolone; Middle Aged; Treatment Outcome; Vertigo | 2016 |
Ototoxicity in children with malignant brain tumors treated with the "8 in 1" chemotherapy protocol.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Drug Administration Schedule; Evaluation Studies as Topic; Female; Follow-Up Studies; Hearing Loss; Humans; Hydroxyurea; Incidence; Infant; Lomustine; Male; Methylprednisolone; Procarbazine; Radiation Injuries; Risk Factors; Vincristine | 1996 |
9 other study(ies) available for methylprednisolone and Deafness, Transitory
Article | Year |
---|---|
Mid-term evaluation of perioperative i.v. corticosteroid treatment efficacy on overall and audiological outcome following CO
Topics: Adult; Audiometry, Pure-Tone; Female; Glucocorticoids; Hearing Loss; Humans; Infusions, Intravenous; Laser Therapy; Lasers, Gas; Male; Methylprednisolone; Middle Aged; Otosclerosis; Perioperative Care; Retrospective Studies; Stapes Surgery; Treatment Outcome | 2020 |
Long-lasting uveitis remission and hearing loss recovery after rituximab in Vogt-Koyanagi-Harada disease.
Topics: Administration, Oral; Adolescent; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Antigens, CD20; Audiometry; Cyclosporine; Dexamethasone; Female; Hearing Loss; Hearing Loss, Sensorineural; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Methylprednisolone; Panuveitis; Prednisolone; Prednisone; Prognosis; Recurrence; Remission Induction; Rituximab; Uveitis; Uveomeningoencephalitic Syndrome | 2015 |
Analysis of audio-vestibular assessment in acute low-tone hearing loss.
Topics: Adult; Audiometry, Evoked Response; Audiometry, Pure-Tone; Diuretics; Female; Glucocorticoids; Hearing; Hearing Loss; Humans; Hydrochlorothiazide; Male; Methylprednisolone; Middle Aged; Retrospective Studies; Vestibule, Labyrinth | 2016 |
Incidence and risk factors of postoperative delirium in cervical spine surgery.
Topics: Age Factors; Aged; Aged, 80 and over; Cervical Vertebrae; Chi-Square Distribution; Decompression, Surgical; Delirium; Female; Hearing Loss; Humans; Incidence; Male; Medical Records; Methylprednisolone; Middle Aged; Orthopedic Procedures; Patient Selection; Postoperative Complications; Postoperative Period; Recovery of Function; Retrospective Studies; Risk Factors; Spinal Cord Diseases; Spine | 2009 |
Case of refractory otitis media with high-titer positive serum MPO-ANCA value.
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Antineutrophil Cytoplasmic; Azathioprine; Biomarkers; Drug Therapy, Combination; Female; Hearing Loss; Humans; Methicillin-Resistant Staphylococcus aureus; Methylprednisolone; Middle Aged; Otitis Media with Effusion; Peroxidase; Treatment Outcome | 2010 |
The effect of intratympanic methylprednisolone and gentamicin injection on Ménière's disease.
Topics: Anti-Bacterial Agents; Audiometry, Pure-Tone; Female; Gentamicins; Glucocorticoids; Hearing Loss; Humans; Injections; Male; Meniere Disease; Methylprednisolone; Middle Aged | 2013 |
Susac syndrome: serial diffusion-weighted MR imaging.
Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Arterioles; Brain Diseases; Cognition Disorders; Corpus Callosum; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Headache; Hearing Loss; Humans; Male; Methylprednisolone; Radiography; Remission Induction; Retinal Artery; Retinal Artery Occlusion; Syndrome | 2004 |
Susac syndrome with frontal intermittent rhythmic delta activity (FIRDA).
Topics: Adult; Brain Diseases; Calcium Channel Blockers; Delta Rhythm; Gait Disorders, Neurologic; Hearing Loss; Humans; Lysine; Magnetic Resonance Imaging; Male; Methylprednisolone; Neuroprotective Agents; Nimodipine; Retinal Artery Occlusion; Vision Disorders | 2006 |
Hearing loss in patient with neurobrucellosis.
Topics: Adult; Brucellosis; Female; Hearing Loss; Humans; Meningitis, Bacterial; Methylprednisolone; Nervous System Diseases; Neuroprotective Agents | 2006 |